Clinical Research Associate
Pubblicato il 05-10-2026 - ICON San Antonio in Pavia
Clinical Research Associate II/Senior Clinical Research Associate/ CRA/Sr CRA/ Italy - Milan, Rome, Bologna, Naples
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.
As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.
As a CRA II at ICON, you will design and analyse clinical trials, interpreting complex medical data, and contribute to the advancement of innovative treatments and therapies.
What You Will Do You will contribute to clinical trial monitoring activities, taking responsibility for your deliverables and working collaboratively.
Key Responsibilities Include
- Conducting site qualification, initiation, monitoring, and close-out visits for clinical trials.
- Ensuring protocol compliance, data integrity, and patient safety throughout the trial process.
- Collaborating with investigators and site staff to facilitate smooth study conduct.
- Performing data review and resolution of queries to maintain high-quality clinical data.
- Contributing to the preparation and review of study documentation, including protocols and clinical study reports
Your Profile You will bring relevant clinical trial monitoring experience, along with the following qualifications and skills.
Required Qualifications And Experience
- Bachelor's degree in a scientific or healthcare-related field.
- Minimum of 2 years of experience as a Clinical Research Associate.
- In-depth knowledge of clinical trial processes, regulations, and ICH-GCP guidelines.
- Strong organizational and communication skills, with attention to detail.
- Ability to work independently and collaboratively in a fast-paced environment.
- Willingness to travel as required (approximately 60%)
What ICON Can Offer You Our success depends on the quality of our people. That's why we've made it a prio